All cases of combined carcinoid and non-small cell lung cancer are summarized, focusing on clinical, morphological, and biological features, suggesting the need to recognize and include this entity as a separate class, in particular for its distinct therapeutic implications.
N. Rossi, P. Parente, Luisella Righi et al.· 0 citations
Lung neuroendocrine tumours (NETs, also known as carcinoids) are rapidly rising in incidence worldwide but have unknown aetiology and limited therapeutic options beyond surgery. The current WHO classification, based on mitotic count and presence or absence of necrosis, divides lung NETs into grade-1 typical, and grade-...
A. Sexton-Oates, É. Mathian, N. Candeli et al.· Molecular Cancer· 1 citation
The biological and clinical relevance of the epigenetic landscape of cfDNA in LC patients is explored, particularly focusing on DNA methylation-based biomarkers and their evolving applications towards early diagnosis and post-surgical monitoring of minimal residual disease (MRD).
T. D. Bazan Russo, V. Gristina, M. D. Delcuratolo et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.